Contact inhibition mediates monolayer formation and withdrawal from the cell cycle in vascular endothelial cells. In studying the cyclins-key regulators of the cell cycle-in bovine aortic endothelial cells (BAEC), we found that levels of cyclin A mRNA decreased in confluent BAEC despite the presence of 10% fetal calf serum. We then transfected into BAEC a series of plasmids containing various lengths of the human cyclin A 5 flanking sequence and the luciferase gene. Plasmids containing 3,200, 516, 406, 266, or 133 bp of the human cyclin A promoter directed high luciferase activity in growing but not confluent BAEC. In contrast, a plasmid containing 23 bp of the cyclin A promoter was associated with a 65-fold reduction in activity in growing BAEC, and the promoter activities of this plasmid were identical in both growing and confluent BAEC. Mutation of the activating transcription factor (ATF) consensus sequence at bp ؊80 to ؊73 of the cyclin A promoter decreased its activity, indicating the critical role of the ATF site. We identified by gel mobility shift analysis protein complexes that bound to the ATF site in nuclear extracts from growing but not confluent BAEC and identified (with antibodies) ATF-1 as a binding protein in nuclear extracts from growing cells. Also, ATF-1 mRNA levels decreased in confluent BAEC. Taken together, these data suggest that the ATF site and its cognate binding proteins play an important role in the downregulation of cyclin A gene expression during contact inhibition.
The endothelial cell layer is important in thrombosis, thrombolysis, lymphocyte homing, inflammation, modulation of the immune response, and regulation of vascular tone. Growth inhibition and cell cycle withdrawal mediated by contact, characteristic of most normal cell types, are critical for monolayer formation by vascular endothelial cells both in vivo and in vitro. Yet despite extensive research, little is known about the molecular mechanisms of contact inhibition in these cells (2, 17, 29) .
The progress of the cell cycle is regulated by the sequential expression of cyclins and the activation of their associated cyclin-dependent kinases (Cdks) (22, 43) . p27, a recently identified inhibitor of Cdk2 and Cdk4, is activated in contactinhibited cells (36, 38, 39, 45) . Therefore, the activation of Cdk inhibitors such as p27 may explain in part the process of contact inhibition. It is just as likely, however, that contact inhibition results from downregulation of Cdk activators like the cyclins. Indeed, the cyclin A gene has been identified by differential screening as a gene downregulated at confluence in Mv1Lu cells (40) .
Cyclin A associates with Cdk2 in the S phase of the cell cycle and with Cdc2 in the G 2 /M phase, and it is required for DNA replication in the S phase (6, 13, 32, 37, 43, 44) . Cyclin A can also affect G 1 /S transit, as overexpression of cyclin A overcomes the G 1 /S block induced by loss of cell adhesion (16) . The genomic organization of the human cyclin A gene was published recently (20, 50) . The gene contains eight exons spanning 8 kb of DNA (20) , and multiple transcription start sites have been identified by nuclease S1 protection analysis. The cyclin A promoter contains potential regulatory elements that include four Sp1 sites, beginning at bp Ϫ193, Ϫ170, Ϫ138, and ϩ118; one activating transcription factor (ATF) site, also termed the cyclic AMP (cAMP)-responsive element (CRE) (5, 15, 25, 52) , at bp Ϫ80; two sites that overlap the murine G 1 /S-specific transcription factor Yi (8, 9) , at bp ϩ108 and ϩ112; and two E2F-binding sites (31) , at bp ϩ31 and ϩ165. The cyclin A promoter has been shown to be active in proliferating cells in reporter gene transfection experiments in NIH 3T3 (20) and hamster (48) cells. However, the sequences of the positive regulatory elements mediating cyclin A promoter activity, and their cognate DNA-binding proteins, have not been identified.
In this report, we show that cyclin A mRNA is downregulated by contact inhibition in bovine aortic endothelial cells (BAEC) despite the presence of 10% fetal calf serum. To elucidate the mechanisms of this downregulation, we transfected into BAEC a series of reporter plasmids containing various lengths of the cyclin A 5Ј flanking sequence and the luciferase gene. We found that the ATF motif is critical for cyclin A promoter activity in growing BAEC and for cyclin A downregulation in confluent BAEC. Using gel mobility shift analysis, we identified specific protein complexes that bind to the ATF site in nuclear extract from growing but not confluent BAEC. We then identified (with antibodies) ATF-1 as a protein that binds to the ATF site in nuclear extracts from growing cells and determined that ATF-1 mRNA is downregulated in confluent BAEC.
MATERIALS AND METHODS
Cell culture. BAEC were isolated and cultured in Dulbecco's modified Eagle's medium supplemented with 10% fetal calf serum (HyClone, Logan, Utah) and antibiotics as described previously (26) . BAEC were passaged every 3 to 5 days, and cells from passages 5 to 7 were used for the transfection experiments and for the preparation of RNA and nuclear extracts. Human umbilical vein endothelial cells (HUVEC) were obtained from Clonetics (San Diego, Calif.) and grown in medium 199 containing 20% fetal calf serum (HyClone), 100 g of heparin (Sigma Chemical, St. Louis, Mo.) per ml, and 50 g of endothelial cell growth supplement (Collaborative Biomedical Products, Bedford, Mass.) per ml (51) . HUVEC were passaged every 4 to 5 days, and cells from passages 4 to 6 were used in these experiments. Nuclear extracts from BAEC and HUVEC were prepared as described by Andrews and Faller (1) . Protein concentrations in nuclear extracts were measured by the Bio-Rad (Richmond, Calif.) protein assay system, which is based on the Bradford method (3). Cells were counted in a Coulter apparatus (Coulter Electronics, Hialeah, Fla.).
Cells were plated at a density of about 30,000 cells per cm 2 on a 10-cmdiameter dish (surface area, 55 cm 2 ) for 72 h. For cells to be in confluent stage, the medium was changed to avoid the effect of deprivation of growth factor and the cells were cultured for an additional 24 h before harvesting. Confluence was confirmed by the cell count (200,000 cells per cm 2 ). For cells to be in the growing stage, they were trypsinized, transferred from the 10-cm-diameter dish to a 15-cm-diameter dish (surface area, 140 cm 2 ), and harvested 24 h later. RNA isolation and Northern (RNA) analysis. Total RNA was extracted from growing BAEC with RNAzol B (Tel-Test, Friendswood, Tex.) by the method of Chomczynski and Sacchi (7). A 1.1-kb bovine cyclin A cDNA fragment was amplified by reverse transcriptase-mediated PCR from bovine total RNA (46) . The sequences of the forward (5Ј AAGAGGACCAGGAGAATATCAA 3Ј) and reverse (5Ј TTTTCTCTTATTGACTGTTGTGC 3Ј) primers were derived from the mouse and human cyclin A cDNA sequences reported in the GenBank database. PCR fragments were subcloned, and their sequences were confirmed by the dideoxy-chain termination method (42) .
Total RNA samples from BAEC were fractionated on 1.3% formaldehydeagarose gels and transferred to nitrocellulose filters. The filters were hybridized with a randomly primed 32 P-labeled bovine cyclin A probe. The hybridized filters were washed in 30 mM NaCl-3 mM sodium citrate-0.1% sodium dodecyl sulfate at 55ЊC and autoradiographed on film or stored on phosphor screens for 6 to 8 h (34). To correct for differences in RNA loading, the filters were washed in a 50% formamide solution at 80ЊC and rehybridized with a radiolabeled 18S oligonucleotide. The filters were scanned, and radioactivity was measured on a PhosphorImager running ImageQuant software (Molecular Dynamics, Sunnyvale, Calif.).
Cloning of the human cyclin A gene and construction of plasmids. A 416-bp human cyclin A cDNA fragment was amplified by reverse transcriptase-mediated PCR. Total RNA was extracted from growing HUVEC. The sequences of the forward (5Ј CGTGGACTGGTTAGTTGA 3Ј) and reverse (5Ј ATGGCAAAT ACTTGAGGT 3Ј) primers were based on the published human cyclin A cDNA sequence (49) . The 416-bp fragment was labeled and used to screen a cosmid library prepared from human placenta genomic DNA and the vector SuperCos (Stratagene, La Jolla, Calif.) as described previously (10) . Cosmid clones were purified and DNA was prepared according to standard procedures (42) . Restriction fragments derived from the cosmid clone containing the human cyclin A gene were ligated into plasmid pSP72 (Promega, Madison, Wis.). Nucleotide sequences were determined by the dideoxy-chain termination method (42) . A 3,500-bp SmaI-SmaI restriction fragment (ϳbp Ϫ3200 to ϩ245) and a 761-bp SacI-SmaI fragment (bp Ϫ516 to ϩ245) of the human cyclin A gene were cloned into the promoterless luciferase reporter plasmid pGL2 basic (Promega) in the appropriate orientation. To generate reporter plasmids containing increasingly shorter segments of the cyclin A promoter sequence, we performed PCR with the following primers: plasmid Ϫ406/ϩ205, forward (5Ј AACGTGCCCCAGATTT-TAGACC 3Ј) and reverse (5Ј TGCACTCTGCCCAGCCGAC 3Ј); plasmid Ϫ266/ϩ205, forward (5Ј GGACAGCCTCGCTCACTAGGTG 3Ј) and reverse (5Ј TGCACTCTGCCCAGCCGAC 3Ј); plasmid Ϫ133/ϩ205, forward (5Ј TGCTCAGTTTCCTTTGGTTTACCC 3Ј) and reverse (5Ј TGCACTCTGCCC AGCCGAC 3Ј); plasmid Ϫ23/ϩ205, forward (5Ј AACTGCAAGAACAGCCGC C 3Ј) and reverse (5Ј TGCACTCTGCCCAGCCGAC 3Ј); and plasmid Ϫ133/Ϫ2, forward (5Ј TGCTCAGTTTCCTTTGGTTTACCC 3Ј) and reverse (5Ј GAGC GGCGGCTGTTCTTGCAGTTC 3Ј). Plasmid Ϫ133/ϩ100 was generated by digesting plasmid Ϫ133/ϩ205 with the restriction enzyme XhoI. All PCR fragments were subcloned into pGL2 basic.
We also used PCR to mutate the ATF motif in the human cyclin A gene as described previously (27) . The ATF consensus sequence (TGACGTCA) in plasmid Ϫ266/ϩ205 and plasmid Ϫ133/ϩ205 was mutated to TGCCCCCA by inserting a primer with three mismatched base pairs: forward (5Ј TGAATGCCCC CAAGGCCGCGAG 3Ј) and reverse (5Ј CTCGCGGCCTTGGGGGCATTC A 3Ј). The sequences of the mutated plasmids mt Ϫ266/ϩ205 and mt Ϫ133/ϩ205 were confirmed by the dideoxy-chain termination method.
Transfection and luciferase assays. BAEC were transfected with 15 g of luciferase construct by the calcium phosphate method as described previously (26) . To correct for variability in transfection efficiency, we cotransfected 1 g of pCMV-␤GAL (containing the potent cytomegalovirus enhancer and promoter driving the structural gene coding for ␤-galactosidase) in all experiments. The luciferase assay and ␤-galactosidase assay were performed as described previously (4, 26) , and the ratio of luciferase activity to ␤-galactosidase activity in each sample served as a measure of normalized luciferase activity. Each construct was transfected at least three times, and each transfection was done in triplicate. Data for each construct are presented as the mean Ϯ standard error.
Gel mobility shift assay. Probes were made from DNA fragments of the human cyclin A gene (Ϫ133/Ϫ2 probe) or from double-stranded oligonucleotides synthesized according to the sequence of the cyclin A ATF site (bp Ϫ84 to Ϫ63, 5Ј TGAATGACGTCAAGGCCGCGAG 3Ј). The probes were radiolabeled as described previously (27) . A typical binding reaction mixture contained DNA probe at 20,000 cpm, 1 g of poly(dI-dC) ⅐ poly(dI-dC), 25 mM N-2-hydroxyethylpiperazine-NЈ-2-ethanesulfonic acid (HEPES; pH 7.9), 40 mM KCl, 3 mM MgCl 2 , 0.1 mM EDTA, 1 mM dithiothreitol, 10% glycerol, and 3 g of nuclear extract in a final volume of 25 l. The reaction mixture was incubated at room temperature for 20 min and analyzed by 5% native polyacrylamide gel electrophoresis in 0.25ϫ TBE buffer (22 mM Tris base, 22 mM boric acid, 0.5 mM EDTA). To determine the specificity of the DNA-protein complexes, we performed competition assays with an unlabeled double-stranded oligonucleotide encoding the wild-type ATF sequence or the mutated ATF sequence. To characterize specific DNA-binding proteins, we incubated nuclear extracts with various antibodies for 12 h at 4ЊC before the addition of probe. The polyclonal antibodies (Upstate Biotechnology, Inc., Lake Placid, N.Y.) were raised against human ATF-1, ATF-2, Jun, CRE-binding protein (CREB), and phosphorylated CREB.
RESULTS
Downregulation of cyclin A mRNA in confluent BAEC. To determine whether cyclin A mRNA was downregulated in confluent BAEC, we performed Northern analysis with RNA prepared from confluent BAEC or growing BAEC and a bovine cyclin A probe amplified by PCR. Contact inhibition induced by confluence is very consistent in BAEC, and the density of confluent BAEC does not increase above 200,000 cells per cm 2 despite the presence of 10% fetal calf serum. We routinely use this criterion to ascertain the confluence of BAEC. Cyclin A mRNA was readily detectable in growing BAEC (Fig. 1) ; however, cyclin A mRNA levels were at least fivefold lower in confluent BAEC. In contrast, cyclin D1 mRNA levels did not change significantly in response to confluence (data not shown).
Functional analysis of cyclin A promoter in growing and confluent BAEC. To investigate the mechanisms mediating downregulation of cyclin A gene expression by contact inhibition, we first transfected into BAEC a series of luciferase reporter gene plasmids containing various lengths of the human cyclin A 5Ј flanking sequence. Sixteen to twenty hours after transfection, BAEC were trypsinized, transferred from a 10-cm-diameter plate to a 15-cm-diameter plate (to avoid contact inhibition), and harvested 24 h thereafter. Two reporter plasmids, containing bp Ϫ3200 to ϩ245 and bp Ϫ516 to ϩ245 of the human cyclin A genomic fragment, directed high levels of luciferase activity that were similar to those directed by plasmid pGL2 control (which is driven by the potent simian virus 40 promoter and enhancer) (Fig. 2) . Compared with the luciferase activity of plasmid Ϫ516/ϩ245, the activities of plasmids Ϫ406/ϩ205 and Ϫ266/ϩ205 were 80% higher, suggesting   FIG. 1 . Downregulation of cyclin A mRNA in confluent BAEC. Total RNA was extracted from growing (G) and confluent (C) BAEC. Northern blot analyses were performed with 20 g of total RNA per lane, and results from two independent samples of growing and confluent cells are shown. After electrophoresis, the RNA was transferred to nitrocellulose filters, which were hybridized to a 32 P-labeled cyclin A probe. The filters were also hybridized with the radiolabeled rRNA oligonucleotide 18S to control for differences in loading.
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on January 5, 2018 by guest http://mcb.asm.org/ the presence of silencer elements between bp Ϫ516 and Ϫ407 or bp ϩ206 and ϩ245. Further deletion of the cyclin A 5Ј flanking sequence to 133 bp in plasmid Ϫ133/ϩ205, which lacks three of the four Sp1 sites, decreased promoter activity by 45% (relative to the activities of plasmids Ϫ406/ϩ205 and Ϫ266/ϩ205). Plasmid Ϫ23/ϩ205, which contains only 23 bp of the cyclin A 5Ј flanking sequence, had a 65-fold-lower luciferase activity in comparison with plasmid Ϫ133/ϩ205, indicating the presence of potent positive regulatory elements within bp Ϫ133 to Ϫ23. Two other plasmids with 3Ј deletions, Ϫ133/ ϩ100 and Ϫ133/Ϫ2, had luciferase activities five-to sixfold lower than that of plasmid Ϫ133/ϩ205. Nonetheless, these two plasmids still directed significant luciferase activity in comparison with the promoterless pGL2 basic. Taken together, the data indicate the presence of positive regulatory elements at bp Ϫ266 to Ϫ133, Ϫ133 to Ϫ23, and ϩ100 to ϩ205. Elements within all three areas appear to be necessary for maximal cyclin A promoter activity in growing BAEC; however, elements within bp Ϫ133 to Ϫ23 may be the most important because deletion of this fragment caused the biggest reduction in promoter activity ( Fig. 2 ; compare Ϫ133/ϩ205 with Ϫ23/ϩ205).
To determine whether contact inhibition downregulates cyclin A promoter activity through positive elements in the Ϫ266/ Ϫ133, Ϫ133/Ϫ23, and ϩ100/ϩ205 sequences, we transfected into BAEC the eight plasmids used in the deletion mutant studies described above and harvested cells in the growing or confluent state. For each plasmid, the ratio of luciferase activity in confluent cells versus growing cells was calculated (Fig.  3B) . Luciferase activity in confluent BAEC was markedly lower (5 to 8% of that in growing BAEC) for all plasmids containing the cyclin A promoter except plasmid Ϫ23/ϩ205. In comparison with the other plasmids, plasmid Ϫ23/ϩ205 lacks the sequence within bp Ϫ133 to Ϫ23 that contains the ATF site (bp Ϫ80 to Ϫ73). In addition, there was no difference in the luciferase activity of plasmid Ϫ23/ϩ205 in confluent and growing BAEC (the ratio of confluent to growing cells is 100.6%; Fig. 3 ). These data indicate that the sequence between bp Ϫ133 and Ϫ23 is important in both the downregulation of the cyclin A promoter by contact inhibition in confluent cells and the maintenance of high promoter activity in growing cells. In contrast, the sequences located within bp Ϫ266 to Ϫ133 and bp ϩ100 to ϩ205 appear to be important only to cyclin A promoter activity in growing cells.
To exclude the possibility that downregulation of cyclin A promoter activity by contact inhibition was the result of a nonspecific suppression of transcription, we also transfected into BAEC a plasmid containing the promoter of endothelin-1 (bp Ϫ204 to ϩ150). Endothelin-1 mRNA is expressed in vascular endothelial cells and is not downregulated by confluence. We found that the promoter activity of endothelin-1 in confluent BAEC was no different from that in growing BAEC (data not shown).
Mutation of ATF consensus sequence decreases activity of cyclin A promoter. To determine whether the ATF site (TGACGTCA, bp Ϫ80 to Ϫ73) is the positive regulatory element within the sequence Ϫ133 to Ϫ23, we first mutated the ATF consensus sequence in plasmids Ϫ266/ϩ205 and Ϫ133/ ϩ205 to TGCCCCCA to generate the plasmids mt Ϫ266/ϩ205 and mt Ϫ133/ϩ205 by PCR. The luciferase activities of mt Ϫ266/ϩ205 and mt Ϫ133/ϩ205 were lower in growing BAEC (Fig. 4) . Also, the luciferase activities of these two mutant plasmids in growing BAEC were not significantly different from those in confluent BAEC (data not shown). Thus, the ATF sequence appears to be the positive regulatory element within the Ϫ133 to Ϫ23 sequence.
Confluence downregulates ATF-binding proteins in BAEC.
To characterize the nuclear proteins binding to the positive regulatory element in the sequence Ϫ133 to Ϫ23, we performed gel mobility shift analysis by using a DNA fragment on January 5, 2018 by guest http://mcb.asm.org/ encoding bp Ϫ133 to Ϫ2 of the cyclin A gene as the probe and nuclear extract prepared from growing or confluent BAEC. Incubation of nuclear extract from growing BAEC with the Ϫ133/Ϫ2 probe resulted in two specific protein-DNA complexes, A and B (Fig. 5 ), that were abolished by a 100-fold molar excess of identical nonradiolabeled DNA. A DNA fragment encoding the human cyclin A ATF consensus sequence, but not one encoding the mutated ATF sequence, abolished complex A. Only complex B was present when the probe was incubated with nuclear extract from confluent BAEC, and an excess of unlabeled probe Ϫ133/Ϫ2 abolished the complex. These data indicate the presence of ATF-binding nuclear proteins in growing but not confluent BAEC. We have also used DNA fragments encoding bp Ϫ23 to ϩ205 of the cyclin A gene as probes in gel mobility shift analysis and observed no difference in the binding patterns of nuclear extracts from growing and confluent BAEC (data not shown). Taken together, these data indicate the ATF site as the most important (if not the only) element regulating cyclin A promoter activity during contact inhibition. However, we cannot exclude elements more 5Ј to bp Ϫ3200 of the cyclin A gene. The binding studies described above were performed with a large probe (bp Ϫ133 to Ϫ2). To further characterize the ATF-binding proteins, we performed gel mobility shift analysis with the smaller, 22-bp probe encoding the ATF consensus sequence. Incubation of nuclear extract from growing BAEC with the 22-bp probe resulted in three specific DNA-protein complexes, X, Y, and Z (Fig. 6A) . The three complexes were abolished by an unlabeled oligonucleotide containing the ATF site but not by an oligonucleotide containing a mutated ATF site. In contrast, complex X was not visible, and the density of complexes Y and Z diminished, when the probe was incubated with nuclear extract from confluent BAEC (Fig. 6A) . The disappearance of complexes A (Fig. 5) and X (Fig. 6A ) in response to confluence indicates that they contain similar, if not identical, nuclear proteins.
To identify the ATF-binding proteins present in complexes X, Y, and Z, we performed gel mobility shift analysis in conjunction with antibodies. Because the antibodies had been raised against human antigens, we used in this set of experiments nuclear extract from growing HUVEC. Three complexes identical to the X, Y, and Z complexes found in BAEC were found in HUVEC (Fig. 6B) . Because the ATF site has been shown to bind homo-or heterodimers of proteins of the CREB, ATF, and c-Jun families, we preincubated the nuclear extract with antibodies to ATF-1, ATF-2, c-Jun, CREB, and phosphorylated CREB. Preincubation of growing HUVEC nuclear extract with the antibody to ATF-1 abolished complex X and diminished the density of complexes Y and Z. In contrast, antibodies to ATF-2, c-Jun, and phosphorylated CREB had no effect on the density of these complexes. The anti-CREB antibody completely abolished complexes Y and Z and produced a supershifted DNA-protein-antibody complex (indicated by an asterisk in Fig. 6B ). These results suggest the presence of ATF-1 in complexes X, Y, and Z and CREB in complexes Y and Z.
It is noteworthy that the blocking effect of the anti-ATF-1 antibody on complexes X, Y, and Z in growing cells (Fig. 6B ) is similar to the inhibitory effect of contact inhibition in confluent cells (Fig. 6A) . To support this conclusion, we confirmed that ATF-1 mRNA levels decreased in confluent BAEC (Fig.  7) . In contrast, ATF-2, c-Jun, and CREB mRNA levels did not decrease in confluent BAEC, suggesting that this downregulation of ATF-1 mRNA levels is not due to a universal inhibition of gene transcription. Taken together, these data suggest that the ATF site and its cognate binding proteins play an important role in the downregulation of cyclin A gene expression during contact inhibition.
DISCUSSION
In this report, we show that levels of cyclin A mRNA decrease markedly in response to contact inhibition in vascular endothelial cells. This observation is consistent with an earlier report in which cyclin A was identified by differential screening as one of the downregulated genes in confluent Mv1Lu cells (40) . Downregulation during confluence of cyclin A mRNA ( Fig. 1) but not that of other cyclins such as D1 (data not shown) also suggests that cyclin A, which is important in the   FIG. 4 . Mutation of the ATF site markedly decreases the promoter activity of the cyclin A gene. The ATF site in plasmids Ϫ266/ϩ205 and Ϫ133/ϩ205 was mutated from TGACGTCA to TGCCCCCA by PCR. The wild-type and mutated plasmids were transfected into BAEC, and luciferase activity was measured in growing cells as described in Materials and Methods. VOL. 15, 1995 REGULATION OF CYCLIN A PROMOTER BY ATF SITE 3269 G 1 /S transition and the S and G 2 /M phases of the cell cycle (16, 32) , may be a target for contact inhibition. The cyclin A promoter has been shown to be active in proliferating NIH 3T3 and hamster cells (20, 48) , and the activity of the cyclin A promoter but not the c-fos promoter has been shown to decrease in a hamster cell line carrying a mutation of TAF 250 (48) . However, the exact sequences of the positive regulatory elements and their cognate DNA-binding proteins have not been identified. Our reporter gene transfection experiments identified positive regulatory elements important for cyclin A promoter activity in growing BAEC at bp Ϫ266 to Ϫ133 (containing three Sp1 sites), bp Ϫ133 to Ϫ23 (containing an ATF site), and bp ϩ100 to ϩ205 (containing two overlapping Yi sites, one Sp1 site, and one E2F site) (Fig. 2) . The promoter activities of plasmid Ϫ133/ϩ205 (lacking three of the four Sp1 sites) and plasmid Ϫ133/Ϫ2 (lacking the Yi, Sp1, and E2F sites) were also downregulated by contact inhibition. Although it has been reported that the Yi and the E2F sites are important in the regulation of cell cycle-dependent gene expression (8, 9, 30, 31) , our results indicate that these sequences do not appear to be important in suppressing cyclin A gene expression during contact inhibition (Fig. 3) . In contrast, our observations suggest that the ATF site within bp Ϫ133 to Ϫ23 of the human cyclin A gene is important in the downregulation of the cyclin A promoter by contact inhibition (Fig. 3 and 4) . ATF sites are present in many viral and cellular promoters (5, 15, 25, 52) . Three families of leucine zipper proteins-CREB, ATF, and c-Fos/c-Jun-have been shown to activate or inhibit gene expression by binding to ATF sites as homo-or heterodimers (11, 15, 25, 33, 47, 52) . As a consequence of heterodimer formation, transcriptional cross-talk can be expected to occur between different signaling pathways (35) . For example, in addition to homodimers, CREB and ATF-1 form heterodimers both in vitro and in vivo (21, 23) . Both CREB and ATF-1 can be activated by cAMP and regulate expression of cAMP-responsive genes (14, 41) . However, ATF-1 and other members of the ATF family also mediate cAMP-independent transcription of genes containing ATF sites (18, 19, 28) . After electrophoresis, the RNA was transferred to nitrocellulose filters, which were hybridized sequentially to a 32 P-labeled ATF-1 probe (19) , an ATF-2 probe (19), a c-Jun probe (27) , and a CREB probe (14) . The filters were also hybridized with the radiolabeled rRNA oligonucleotide 18S to correct for differences in loading.
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Although members of the CREB/ATF family have been implicated in the regulation of growth (12, 24) , evidence for a direct link between members of the CREB/ATF family and regulators of the cell cycle has not been available. Our results indicate that nuclear proteins binding to the cyclin A ATF site are downregulated by contact inhibition (Fig. 5 and 6A ). Using specific antibodies in conjunction with gel mobility shift analysis, we identified ATF-1 as one such protein (Fig. 6B ). This identification is further supported by our observation that the mRNA levels of ATF-1 decrease after contact inhibition (Fig.  7) . ATF-1 could bind to the cyclin A ATF site as a homodimer, or as a heterodimer with CREB or another unidentified nuclear protein, to regulate the activity of the cyclin A promoter. In any case, our observations establish a direct link between members of the ATF/CREB family and the regulators of the cell cycle. Furthermore, elucidation of the mechanisms downregulating ATF-1 gene expression will provide important insight into the signaling pathways of contact inhibition.
